SCHEMBL23713472

SCHEMBL23713472

CCc1ccc2cc(-c3ccccc3C(F)(F)F)c(=O)oc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
TRPA1 O75762 1/20 0.44
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
MIF P14174 3/20 0.43
GLA P06280 2/20 0.42
TP53 P04637 2/20 0.42
NPC1 O15118 5/20 0.40
MAPT P10636 5/20 0.40
LMNA P02545 4/20 0.40
RAB9A P51151 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
USP2 O75604 2/20 0.40
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
C1R P00736 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21524281 0.83 MAOB (0.51) CYP19A1MIFC1R
SCHEMBL27935835 0.83 MEN1 (0.44) CYP19A1KDM4EHPGDMIFGLA
SCHEMBL23713558 0.82 RAB9A (0.53) CYP19A1TRPA1KDM4EHPGDGLA
SCHEMBL30568051 0.82 S1PR1 (0.41) CYP19A1KDM4EHPGDMIFGLA
SCHEMBL18523588 0.82 S1PR1 (0.41) CYP19A1KDM4EHPGDMIFGLA
SCHEMBL22590858 0.81 RAB9A (0.57) KDM4EHPGDGLATP53NPC1
SCHEMBL18535489 0.81 MIF (0.65) KDM4EHPGDMIFGLANPC1
SCHEMBL18523595 0.81 MAOB (0.51) CYP19A1KDM4EHPGDMIFTP53
SCHEMBL18583699 0.81 MIF (0.45) CYP19A1KDM4EHPGDMIFGLA
SCHEMBL21524279 0.80 NPC1 (0.64) KDM4EHPGDMIFGLATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A CYP19A1 1773/4885TRPA1 16/4885KDM4E 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.